Randomisation: Patients with diabetes and presumed NASH were randomised, using permuted blocks without additional stratification, into one of three treatment groups, in a 1:1:1 ratio as follows: (1) BUDCA 500 mg BID (2) 1000 mg BID, and (3) matching placebo
As with any actively studied peptide, staying current with published literature matters as much as sourcing the compound correctly
doi: 10.1210/clinem/dgaa327 47 NauckMAQuastDRWefersJPfeifferAFH
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
As time passes, environmental stressors and biological aging can disrupt these delicate systems
Conclusion At Pacific Sound Plastic Surgery, we understand that weight loss is a highly personal journey